NEWTON, Mass.--(BUSINESS WIRE)--Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, today announced it has entered into a collaboration with Mayo Clinic to ...
TORONTO—Use of an oral phosphodiesterase type-5 inhibitor (PDE5i) significantly reduces urinary incontinence after radical prostatectomy (RP), according to data presented at the joint annual meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results